VectivBio Holding AG (VECT) Stock Analysis
DELISTED 2023
What happened to VectivBio Holding AG (VECT) stock?
VectivBio Holding AG (VECT) no longer trades on public markets. It was delisted in July 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2023
- Last recorded price (historical):
- $16.87 (last quote on record before the July 2023 delisting; historical, not a current quote)
Market cap $1.06B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
VectivBio Holding AG (VECT). VectivBio Holding AG is a clinical-stage biopharmaceutical company focused on developing treatments for severe rare conditions. Their lead product, apraglutide, targets short bowel syndrome-intestinal failure (SBS-IF) and steroid-refractory gastrointestinal acute versus host disease (aGvHD).
Last analyzed: Mar 18, 2026VectivBio Holding AG (VECT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VECT shares?
No. VECT stopped trading on public markets in July 2023, so the shares are not available through a broker. Anything you see quoted for VECT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VECT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to VectivBio Holding AG. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.